Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...

Dr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest drugmaker, declined by 3.2% to Rs 1,647.35, becoming the top loser on the BSE ...

Indian drugmakers earn a significant share of revenue from the U.S., the largest importer of Indian pharma products. India's pharma exports to the country stood at $8.73 billion in fiscal 2024 - a ...

Then came the threats of tariffs that the Indian pharma sector could face in the United States. How turbulent could the after-effects be of the possible tariffs? “The key strength of Indian ...

Premium Quality Power IPO Day 2 Highlights: The subscription period for the Quality Power IPO is scheduled from Friday, February 14, to Tuesday, February 18. Quality Power IPO Day 2 Highlights ...

NATCO Pharma faced a sharp decline, with a 37.75% drop in net profit in Q3 to Rs 132.4 crore due to lower formulation exports. Despite a rise in API revenue, the overall performance suffered. The ...

Natco Pharma Share Price: Shares of NATCO Pharma plunged 20% on Thursday, February 13, after the company reported a decline in revenue, profit, and operating income for the third quarter of fiscal ...

Gesynta Pharma raises $27 M for Phase II clinical trial for Vipoglanstat, a novel drug therapy to ... [+] treat endometriosis. Endometriosis is a chronic inflammatory disease that impairs the ...

CEO John Kite highlighted that 2024 was an exceptional year, with the company leasing 5 million square feet, its highest volume in history. Weighted average rent bumps for new and non-option ...

That's especially true among millennials and GenZ demos, according to Atomik Research. And Kite Hill couldn't be happier. The brand kicked off its #DairyFreeFeb to highlight the benefits of diary ...

Global private equity firms Blackstone (NYSE: BX), Brookfield Corporation (TSX:BN) and Warburg Pincus are in talks to acquire a majority stake in Hyderabad, India-based Gland Pharma from China's ...